Mary endpoint could be elevated from 30 0 inside a study population of
Mary endpoint would be improved from 30 0 within a study population of 30 sufferers. Twelve patients (median age 64 years; 67 male, 58 moderately differentiated, 83 esophageal, 100 HER2positive)…